We are live on
!
Find out more
Sanofi
SNY
SNY
484 hedge funds and large institutions have $11.5B invested in Sanofi in 2017 Q3 according to their latest regulatory filings, with 50 funds opening new positions, 145 increasing their positions, 171 reducing their positions, and 35 closing their positions.
New
Increased
Maintained
Reduced
Closed
43% more first-time investments, than exits
New positions opened: 50 | Existing positions closed: 35
2% more funds holding
Funds holding: 474 → 484 (+10)
1% more capital invested
Capital invested by funds: $11.3B → $11.5B (+$138M)
0.52% less ownership
Funds ownership: 18.66% → 18.15% (-0.52%)
4% less call options, than puts
Call options by funds: $30.7M | Put options by funds: $32M
10% less funds holding in top 10
Funds holding in top 10: 10 → 9 (-1)
15% less repeat investments, than reductions
Existing positions increased: 145 | Existing positions reduced: 171
Holders
484
Holders Change
+10
Holders Change %
+2.11%
% of All Funds
12.07%
Holding in Top 10
9
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-10%
% of All Funds
0.22%
New
50
Increased
145
Reduced
171
Closed
35
Calls
$30.7M
Puts
$32M
Net Calls
-$1.26M
Net Calls Change
-$78.8M
Top Buyers
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
+$109M |
| 2 |
SCA
Southpoint Capital Advisors
New York
|
+$38.7M |
| 3 |
SAM
Senzar Asset Management
New York
|
+$38.6M |
| 4 |
BlackRock
New York
|
+$33.2M |
| 5 |
Boston Partners
Boston,
Massachusetts
|
+$24.4M |
